Long-term outcomes for heart attack patients treated with a naturally-dissolving blood vessel support

Bioresorbable scaffold implantation in STEMI patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN43696201

Enrollment

130

Registered

2019-06-07

Start date

2012-12-15

Completion date

Unknown

Last updated

2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction with ST segment elevation Circulatory System

Interventions

Use of bioresorbable scaffold (AbsorbTM BRS) during primary coronary intervention. Patients enrolled in this study were treated during primary percutaneous coronary intervention (PCI)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. STEMI patients 2. Sign informed consent

Exclusion criteria

Exclusion criteria: 1. Severe calcification 2. Do not meet specified vessel size 3. Length of the lesion more than 28mm 4. Indication for anticoagulation, cardiogenic shock

Design outcomes

Primary

Measure	Time frame
At 5 years: 1. Death using patient records 2. MI using patient records 3. Target vessel revascularization as recorded in records by a specialist	—

Secondary

Measure	Time frame
Vessel invasive assessment using QCA and optical coherence tomography at baseline and 5 years.	—

Countries

Czech Republic

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 28, 2026